简体中文 | 繁體中文 | English

Press Releases

2019-06-12 14:54 Global Study from Egon Zehnder Reveals the Challenges Facing the First Generation of Chief Digital Officers
2019-06-12 11:44 CES Asia 2019 Unveils Next-Gen Innovation on Opening Day
2019-06-12 10:10 Wipro Rolls Out Total Operations System (TOPS) CREW for Global Airlines
2019-06-12 09:48 Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance
2019-06-12 09:44 NTT Proposes the “Digital Twin Computing Initiative” – a Platform to Combine High-Precision Digital Information Reflecting the Real World to Synthesize Diverse Virtual Worlds, Generate Novel Services and Bring about Society of the Future
2019-06-12 09:41 Smartlands lanceert uniek platform voor Crowdfunding Investment, wordt het eerste bedrijf dat onroerend goed in het VK ontwikkelt via tokens
2019-06-11 18:24 Higher Ground Announces Partnership with Spotify to Produce Podcasts
2019-06-11 18:17 CES Asia 2019 Exhibitor Profiles
2019-06-11 18:15 New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought
2019-06-11 16:25 Orbital Insight Expands Asia Presence with New Singapore Office
2019-06-11 16:18 Microsure’s MUSA Microsurgery Robot Receives CE-mark
2019-06-11 15:59 Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics
2019-06-11 13:58 PVH Corp. Names Cheryl Abel-Hodges Chief Executive Officer of Calvin Klein, Inc.
2019-06-11 13:52 ondon Tech Entrepreneur Tej Kohli Pours $100m into AI & Machine Learning Ventures
2019-06-11 13:42 Andrew Keys Joins DARMA Capital as Managing Partner
2019-06-11 13:36 Alibaba A. I. Labs Partners with Audi, Renault and Honda for Intelligent In-car Experience
2019-06-11 12:01 Fashion Icon Jason Wu to Take the Stage at CES Asia 2019
2019-06-11 10:01 Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®
2019-06-11 09:55 Rahi Systems Acquires Serro, PiTek
2019-06-11 09:35 New post-hoc analysis shows consistent cardiorenal risk reductions of empagliflozin in a sub-group of adults with type 2 diabetes and chronic kidney disease without overt proteinuria